STOCK TITAN

908 Devices Inc. Stock Price, News & Analysis

MASS Nasdaq

Welcome to our dedicated page for 908 Devices news (Ticker: MASS), a resource for investors and traders seeking the latest updates and insights on 908 Devices stock.

908 Devices Inc. (MASS) delivers innovative mass spectrometry solutions enabling real-time chemical analysis across safety, life sciences, and industrial sectors. This news hub provides investors and professionals with essential updates on corporate developments and technological advancements.

Access timely press releases, earnings reports, and strategic announcements in one centralized location. Our curated collection includes regulatory filings, product launch details, and partnership updates critical for understanding the company's market position.

Key updates cover:
- Financial performance and investor communications
- Breakthroughs in handheld/desktop analysis devices
- Industry-specific applications in biotech and forensics
- Global expansion initiatives and regulatory milestones

Bookmark this page for streamlined access to MASS's evolving story. Combine our news archive with SEC filings and market analysis tools for comprehensive due diligence.

Rhea-AI Summary

908 Devices (NASDAQ: MASS) reported strong Q2 2025 financial results, with total revenue reaching $13.0 million, up 14% year-over-year. The company's recurring revenue grew 28% to $4.7 million, representing 36% of total revenues.

Key operational highlights include record XplorIR device placements, the launch of VipIR analyzer, and the completion of manufacturing consolidation. The company also acquired KAF Manufacturing for $2.75 million and secured a $6.6 million OEM supply commitment. The installed base grew 27% to 3,336 devices.

Despite posting a net loss of $12.9 million, 908 Devices raised its 2025 revenue outlook to $54-56 million, representing 13-17% growth. The company maintains a strong balance sheet with $118.6 million in cash and no debt.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.76%
Tags
-
Rhea-AI Summary

908 Devices (NASDAQ:MASS), a pioneer in handheld chemical analysis devices, has appointed Dr. Brandi Vann to its Board of Directors. Dr. Vann brings over 15 years of experience from the U.S. Department of Defense, where she served as Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense.

The appointment comes as part of the company's strategic refocus on public health, safety, and defense technology. Simultaneously, Jeff George has stepped down from the Board. Dr. Vann's extensive experience includes leadership roles at the Defense Threat Reduction Agency and oversight of critical defense programs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.56%
Tags
management
-
Rhea-AI Summary

908 Devices (NASDAQ:MASS), a company specializing in handheld chemical analysis tools for health, safety, and defense applications, has announced its participation in the Canaccord Genuity 45th Annual Growth Conference. The company's management team will deliver a presentation on Wednesday, August 13 at 1:00 PM Eastern Time. Investors can access both the live and archived versions of the presentation through the investor relations section of 908 Devices' website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.18%
Tags
conferences
Rhea-AI Summary

908 Devices (NASDAQ:MASS), a company specializing in handheld chemical analysis tools for health, safety, and defense applications, has scheduled its second quarter 2025 financial results announcement for August 5, 2025, before market open.

Management will host a conference call and webcast at 8:30 AM ET to discuss the results. Investors can access the live webcast through the company's website at www.908devices.com, with a replay available within 24 hours after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
conferences earnings
-
Rhea-AI Summary

908 Devices (NASDAQ:MASS) has launched VipIR, a groundbreaking 3-in-1 handheld chemical analyzer designed for field-based identification of unknown bulk substances. The device features Smart Spectral Processing (SSP), a proprietary algorithm that integrates both Raman and FTIR spectroscopy technologies into a single workflow.

VipIR includes an extensive library of over 39,000 chemical spectra and is equipped with built-in Wi-Fi and cellular connectivity. The device is specifically designed for customs, border personnel, and hazardous response teams to identify narcotics, explosives, and toxic chemicals efficiently in the field.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.24%
Tags
none
-
Rhea-AI Summary

908 Devices (NASDAQ:MASS) partnered with Asylon Robotics to deploy gas-detecting security robots at the 2025 Indianapolis 500, the world's largest single-day sporting event with over 300,000 attendees. The collaboration featured Asylon's DroneDog-2 units equipped with 908 Devices' InterceptIR sensor for real-time air monitoring and surveillance.

The autonomous robots, built on Boston Dynamics' Spot® platform, successfully navigated GPS-denied tunnels beneath the track, maintaining operations through secure mesh communications and Starlink backup. The integration with Asylon's DroneIQ software provided emergency personnel with continuous access to live video, threat alerts, and gas detection readings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.42%
Tags
none
Rhea-AI Summary
908 Devices (MASS) announced that the Metropolitan Washington Council of Governments (COG) has acquired eight XplorIR devices for hazardous materials response. The devices, delivered in Q1 2025 with training in Q2 2025, will be distributed across seven counties and the District of Columbia. The handheld XplorIR can detect, identify, and quantify 5,000 different gas and vapor chemical threats within seconds. Built for harsh environments with simple controls and intuitive display, the device enhances first responders' ability to manage emergency situations. The COG, an independent nonprofit association, coordinates regional public safety and homeland security planning across DC, Maryland, and Virginia.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.26%
Tags
none
-
Rhea-AI Summary

908 Devices (NASDAQ: MASS) announced that the Romanian Customs Authority has successfully deployed 27 MX908 devices across its border operations for enhanced security measures. The handheld mass spectrometers, delivered earlier this year, enable real-time identification of trace chemicals, particularly drugs and explosives. The devices can detect trace levels of substances on vehicles, containers, and packages within seconds, allowing customs officials to make quick, informed decisions during inspections.

The order was secured through 908 Devices' channel partner, MATE-FIN, via an EU Customs Control Equipment Instrument program. The deployment and training were completed in early 2025, strengthening Romania's border security capabilities and its contribution to European Community safety.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.56%
Tags
none
-
Rhea-AI Summary
908 Devices (NASDAQ: MASS) reported strong Q1 2025 financial results with total revenue reaching $11.8 million, up 59% year-over-year. The company's handheld product and service revenue grew 86% to $11.0 million. Recurring revenue increased 54% to $4.4 million, representing 37% of total revenues. The installed base expanded 28% to 3,172 devices. Despite revenue growth, the company reported a net loss from continuing operations of $9.8 million. Notable achievements include a $2.0 million order from Texas Department of Public Safety and shipment of over 25 MX908 devices for Ukraine. The company divested its bioprocessing portfolio to Repligen, resulting in a net gain of $56.6 million. 908 Devices maintains its 2025 revenue guidance of $53-55 million, projecting 11-15% growth. Cash position stands strong at $124.3 million with no debt.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.85%
Tags
Rhea-AI Summary

908 Devices has secured significant contracts to supply advanced chemical detection devices to the European Union's rescEU disaster preparedness initiative. The company has delivered 108 devices to EU member states over the past six months.

Key deployments include:

  • Czech Fire Brigade: 6 MX908 mass spectrometry devices for Q2 2025, adding to their existing 12 devices (XplorIR and ThreatID)
  • Finland: 90 ProtectIR handheld FTIR analyzers, delivered across Q4 2024 and Q1 2025

These devices enhance disaster response capabilities by enabling rapid identification of chemical, biological, radiation, and nuclear (CBRN) threats. The MX908 can detect hazardous substances in multiple forms, while ProtectIR can identify over 23,000 chemical substances.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none

FAQ

What is the current stock price of 908 Devices (MASS)?

The current stock price of 908 Devices (MASS) is $6.34 as of August 5, 2025.

What is the market cap of 908 Devices (MASS)?

The market cap of 908 Devices (MASS) is approximately 230.2M.
908 Devices Inc.

Nasdaq:MASS

MASS Rankings

MASS Stock Data

230.23M
32.84M
8.42%
73.17%
6.01%
Medical Devices
Measuring & Controlling Devices, Nec
Link
United States
BOSTON